Brief: Aadi Bioscience Enters Into Amendment With Fresenius Kabi

Whitehawk Therapeutics

23/01/2023 11:18

Jan 23 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE-ON JAN 17,ENTERED INTO AMENDMENT TO
NEGOTIATED
PURCHASE ORDER TERMS, CONDITIONS FOR CLINICAL, COMMERCIAL
PRODUCT WITH FRESENIUS KABI
    * AADI BIOSCIENCE INC - PURSUANT TO AMENDMENT, TERM OF
AGREEMENT
WAS EXTENDED UNTIL MARCH 31, 2024

Further company coverage:  AADI.O 
 ((Reuters.Briefs@thomsonreuters.com;))